News1 min ago
Nordic Bioscience’s unique biomarker PRO-C3 gets green light for further study in cancer from US FDA in formal Letter of Support
Paves way for further testing of the PRO-C3 biomarker assay, which identifies patients with hard to treat ‘fibrotic’ tumors, in further clinical trials US FDA recognizes...
